Company profilePharmaceutical#1127 of 1,318 in Pakistan✓ No DRAP alerts

Cure Inn Phytoceuticals

Pharmaceutical company · 2 brands · 1 molecules

Ranked #68 of 74 companies in Pain Management

2 registered products 1 pharmaceutical brands 1 distinct molecules 0 DRAP alerts

Company overview

2
registered products
1
pharmaceutical brands
1
distinct molecules
2
therapeutic classes
0
DRAP alerts

Cure Inn Phytoceuticals is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 2 product registrations across 1 distinct molecules. Its portfolio is concentrated in Pain Management and Fever/Flu/Cough. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Cure

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 1

Top molecules by brand count

Therapeutic classes

Pain Management · 1Fever/Flu/Cough · 1

Conditions treated

Pain Killers · 1Cold/Cough/Flu · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 23.75 – Rs 23.75
Servaid2 products · Rs 95 – Rs 750
Median across source: Rs 422.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

AGP (PRIVATE) LTD.1 shared molecules
Remedies International1 shared molecules
Delta Enterprises1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Next Pharmaceutical Products (Pvt.) Ltd holds 48 molecules not in this portfolio
AmlodipineAprepitantArginineArtemetherAtorvastatinAtorvastatin Calcium
AGP (PRIVATE) LTD. holds 142 molecules not in this portfolio
AmikacinAminophyllineAmlodipineAmoxicillinAprepitantArtemether
HIGHNOON LABORATORIES LIMITED holds 164 molecules not in this portfolio
000 I.U5-Fluorouracil 500MgAceclofenacAcyclovirAcyclovir Inf/OralAmlodipine

Get the full profile for Cure

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.